One-year outcomes after photodynamic therapy in patients with age-related macular degeneration with poor baseline visual acuity

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 8, 2006, Pages 1026-1028

  Potter, Michael J ^a   Szabo, Shelagh M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Clinical study; Photodynamic therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33746902332     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0204-3     Document Type: Article

References (7)

1. Axer-Siegel R, Ehrlich R, Yassur Y et al. (2004) Photodynamic therapy for age-related macular degeneration in a clinical setting: Visual results and angiographic patterns. Am J Ophthalmol 137:258-264
2. Essex RW, Quershi SH, Cain MS, Harper CA, Guymer RH (2003) Photodynamic therapy in practice: A review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital. Clin Exp Ophthalmol 31:476-481
3. Talks SJ, Setty R, Clarke L (2004) The incidence and outcome of photodynamic therapy for macular degeneration in the Northern region of the UK. Eye 18:588-594
4. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP Report 1. Arch Ophthalmol 117:1329-1345
5. Verteporfin in Photodynamic Therapy (VIP) Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-VIP Report #2. Am J Ophthalmol 131:541-560
6. Verteporfin Roundtable 2000 and 2001 Participants (2002) Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 22:6-18
7. Verteporfin Roundtable Participants (2005) Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: Update. Retina 25:119-134